Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2

Cancer Res. 2007 Sep 15;67(18):8429-32. doi: 10.1158/0008-5472.CAN-07-1684.

Abstract

Recent findings indicate that tumor-associated macrophages are important drivers of tumor angiogenesis. Here, we review the essential role played by Tie2-expressing monocytes (TEM) in this phenomenon. TEMs are present in human blood and tumors and their elimination in various tumor models suppresses tumor angiogenesis. A ligand for Tie2, angiopoietin-2 (Ang-2), is produced by angiogenic tumor vessels and is a chemoattractant for TEMs. Hypoxia up-regulates Tie2 expression on TEMs and, together with Ang-2, down-regulates their antitumor functions. Learning more about the regulation of TEMs by the tumor microenvironment may yield new strategies to ablate the tumor vasculature.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiopoietin-2 / biosynthesis
  • Angiopoietin-2 / genetics
  • Angiopoietin-2 / metabolism*
  • Animals
  • Cell Hypoxia
  • Humans
  • Monocytes / enzymology*
  • Neoplasms / blood
  • Neoplasms / blood supply*
  • Neoplasms / enzymology*
  • Neoplasms / genetics
  • Neovascularization, Pathologic / blood
  • Neovascularization, Pathologic / enzymology
  • Receptor, TIE-2 / biosynthesis*
  • Receptor, TIE-2 / genetics
  • Up-Regulation

Substances

  • Angiopoietin-2
  • Receptor, TIE-2